Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer

In this paper, we aim to evaluate the entity of inter-fraction organ motion and deformation in stereotactic body radiotherapy (SBRT) treatments for nodal oligometastatic prostate cancer (PCa). Thirty-three patients with lymph nodes showing oligometastatic PCa treated with SBRT were included. Organs...

Full description

Bibliographic Details
Main Authors: Francesco La Fauci, Matteo Augugliaro, Giovanni Carlo Mazzola, Stefania Comi, Matteo Pepa, Mattia Zaffaroni, Maria Giulia Vincini, Giulia Corrao, Francesco Alessandro Mistretta, Stefano Luzzago, Cristiana Fodor, Gennaro Musi, Salvatore Gallo, Giuseppe Petralia, Ottavio De Cobelli, Roberto Orecchia, Federica Cattani, Giulia Marvaso, Barbara Alicja Jereczek-Fossa
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/21/10949
_version_ 1797469241658572800
author Francesco La Fauci
Matteo Augugliaro
Giovanni Carlo Mazzola
Stefania Comi
Matteo Pepa
Mattia Zaffaroni
Maria Giulia Vincini
Giulia Corrao
Francesco Alessandro Mistretta
Stefano Luzzago
Cristiana Fodor
Gennaro Musi
Salvatore Gallo
Giuseppe Petralia
Ottavio De Cobelli
Roberto Orecchia
Federica Cattani
Giulia Marvaso
Barbara Alicja Jereczek-Fossa
author_facet Francesco La Fauci
Matteo Augugliaro
Giovanni Carlo Mazzola
Stefania Comi
Matteo Pepa
Mattia Zaffaroni
Maria Giulia Vincini
Giulia Corrao
Francesco Alessandro Mistretta
Stefano Luzzago
Cristiana Fodor
Gennaro Musi
Salvatore Gallo
Giuseppe Petralia
Ottavio De Cobelli
Roberto Orecchia
Federica Cattani
Giulia Marvaso
Barbara Alicja Jereczek-Fossa
author_sort Francesco La Fauci
collection DOAJ
description In this paper, we aim to evaluate the entity of inter-fraction organ motion and deformation in stereotactic body radiotherapy (SBRT) treatments for nodal oligometastatic prostate cancer (PCa). Thirty-three patients with lymph nodes showing oligometastatic PCa treated with SBRT were included. Organs at risk (OARs) were delineated using both simulation computer tomography (s-CT) and daily cone beam CTs (CBCTs) using the Raystation planning system. For each OAR, the union volume (UV) between all the CBCTs and s-CT was computed. An expanded volume (EV) of the s-CT OARs was applied using six different margins (3, 5, 8, 10, 15, and 20 mm). A percentage volume (V%) was computed to assess the intersection between each EV and UV. The OAR deformation and motion were further evaluated using the dice similarity coefficient (DSC) and mean distance to agreement (Mean_DA). The percentage maximum dose variations for all the OARs were estimated. A recalculation with higher dose prescriptions was performed by prescribing 36 Gy/3 fx, as well as 45 Gy/3 fx. The cauda showed the highest matching (DSC = 0.72; Mean_DA = 0.14 cm), and the colon showed the lowest one (DSC = 0.37; Mean_DA = 0.44 cm). The minimum margin, which ensured a V% > 95%, was 3 mm (97.5%) for the cauda and 15 mm (96.6%) for the colon. All the OARs reached the compliance of the constraints in each session. Regarding 36 Gy-plans, the ileum punctual compliance Dmax failed in 58.8% of patients, and it failed in 70.6% of the patients for the ileum, 7.14% for the colon, and 12.5% for the bladder in the case of 45 Gy-plans. This study is an ancillary study of the RADIOSA clinical trial (AIRC IG-22159) and can be used as a benchmark for dose escalation.
first_indexed 2024-03-09T19:18:36Z
format Article
id doaj.art-ecc3126ce5f248e6b511b9d3a7136216
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-09T19:18:36Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-ecc3126ce5f248e6b511b9d3a71362162023-11-24T03:35:32ZengMDPI AGApplied Sciences2076-34172022-10-0112211094910.3390/app122110949Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate CancerFrancesco La Fauci0Matteo Augugliaro1Giovanni Carlo Mazzola2Stefania Comi3Matteo Pepa4Mattia Zaffaroni5Maria Giulia Vincini6Giulia Corrao7Francesco Alessandro Mistretta8Stefano Luzzago9Cristiana Fodor10Gennaro Musi11Salvatore Gallo12Giuseppe Petralia13Ottavio De Cobelli14Roberto Orecchia15Federica Cattani16Giulia Marvaso17Barbara Alicja Jereczek-Fossa18Unit of Medical Physics, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyUnit of Medical Physics, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDepartment of Physics “Aldo Pontremoli”, University of Milan, 20133 Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyScientific Directorate, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyUnit of Medical Physics, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, ItalyIn this paper, we aim to evaluate the entity of inter-fraction organ motion and deformation in stereotactic body radiotherapy (SBRT) treatments for nodal oligometastatic prostate cancer (PCa). Thirty-three patients with lymph nodes showing oligometastatic PCa treated with SBRT were included. Organs at risk (OARs) were delineated using both simulation computer tomography (s-CT) and daily cone beam CTs (CBCTs) using the Raystation planning system. For each OAR, the union volume (UV) between all the CBCTs and s-CT was computed. An expanded volume (EV) of the s-CT OARs was applied using six different margins (3, 5, 8, 10, 15, and 20 mm). A percentage volume (V%) was computed to assess the intersection between each EV and UV. The OAR deformation and motion were further evaluated using the dice similarity coefficient (DSC) and mean distance to agreement (Mean_DA). The percentage maximum dose variations for all the OARs were estimated. A recalculation with higher dose prescriptions was performed by prescribing 36 Gy/3 fx, as well as 45 Gy/3 fx. The cauda showed the highest matching (DSC = 0.72; Mean_DA = 0.14 cm), and the colon showed the lowest one (DSC = 0.37; Mean_DA = 0.44 cm). The minimum margin, which ensured a V% > 95%, was 3 mm (97.5%) for the cauda and 15 mm (96.6%) for the colon. All the OARs reached the compliance of the constraints in each session. Regarding 36 Gy-plans, the ileum punctual compliance Dmax failed in 58.8% of patients, and it failed in 70.6% of the patients for the ileum, 7.14% for the colon, and 12.5% for the bladder in the case of 45 Gy-plans. This study is an ancillary study of the RADIOSA clinical trial (AIRC IG-22159) and can be used as a benchmark for dose escalation.https://www.mdpi.com/2076-3417/12/21/10949oligometastatic prostate cancerstereotactic body radiotherapycomputed tomographyplanninginter fractionorgan motion
spellingShingle Francesco La Fauci
Matteo Augugliaro
Giovanni Carlo Mazzola
Stefania Comi
Matteo Pepa
Mattia Zaffaroni
Maria Giulia Vincini
Giulia Corrao
Francesco Alessandro Mistretta
Stefano Luzzago
Cristiana Fodor
Gennaro Musi
Salvatore Gallo
Giuseppe Petralia
Ottavio De Cobelli
Roberto Orecchia
Federica Cattani
Giulia Marvaso
Barbara Alicja Jereczek-Fossa
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
Applied Sciences
oligometastatic prostate cancer
stereotactic body radiotherapy
computed tomography
planning
inter fraction
organ motion
title Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
title_full Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
title_fullStr Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
title_full_unstemmed Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
title_short Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
title_sort dosimetric evaluation of the inter fraction motion of organs at risk in sbrt for nodal oligometastatic prostate cancer
topic oligometastatic prostate cancer
stereotactic body radiotherapy
computed tomography
planning
inter fraction
organ motion
url https://www.mdpi.com/2076-3417/12/21/10949
work_keys_str_mv AT francescolafauci dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT matteoaugugliaro dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT giovannicarlomazzola dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT stefaniacomi dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT matteopepa dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT mattiazaffaroni dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT mariagiuliavincini dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT giuliacorrao dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT francescoalessandromistretta dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT stefanoluzzago dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT cristianafodor dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT gennaromusi dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT salvatoregallo dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT giuseppepetralia dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT ottaviodecobelli dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT robertoorecchia dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT federicacattani dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT giuliamarvaso dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer
AT barbaraalicjajereczekfossa dosimetricevaluationoftheinterfractionmotionoforgansatriskinsbrtfornodaloligometastaticprostatecancer